Product NDC: | 0409-9631 |
Proprietary Name: | Furosemide |
Non Proprietary Name: | FUROSEMIDE |
Active Ingredient(s): | 10 mg/mL & nbsp; FUROSEMIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-9631 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075241 |
Marketing Category: | ANDA |
Start Marketing Date: | 19990528 |
Package NDC: | 0409-9631-04 |
Package Description: | 10 CARTON in 1 CONTAINER (0409-9631-04) > 1 SYRINGE, PLASTIC in 1 CARTON > 4 mL in 1 SYRINGE, PLASTIC |
NDC Code | 0409-9631-04 |
Proprietary Name | Furosemide |
Package Description | 10 CARTON in 1 CONTAINER (0409-9631-04) > 1 SYRINGE, PLASTIC in 1 CARTON > 4 mL in 1 SYRINGE, PLASTIC |
Product NDC | 0409-9631 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FUROSEMIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19990528 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | FUROSEMIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |